Trileptal 60 mg/ml, Suspension zum Einnehmen

7680528520216 CH-52852 suspension

Associated product:

TRILEPTAL susp 6 % fl 100 ml
Trileptal 60 mg/ml, Suspension zum Einnehmen
Trileptal 60 mg/ml, Suspension zum Einnehmen
Trileptal 60 mg/ml, Suspension zum Einnehmen
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
ml
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/08/2025
Patient information leaflet
Français
05/08/2025
Patient information leaflet
Italien
05/08/2025
Summary of Product Characteristics
Allemand
05/08/2025
Summary of Product Characteristics
Français
05/08/2025
Summary of Product Characteristics
Italien
05/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
250.0 MG Substance HBESI
(N/A)
25.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HIMDK
(N/A)
- Substance ANTOX
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
0.3 MG Substance HBESI
(N/A)
1.2 MG Substance HBESI
(N/A)
1.38 MG Substance HBESI

Reimbursement information

Public price
CHF 29.55
Specialties list
Yes
Generic
No
SL addition date: 01/02/2006

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
52852
Drug name
Trileptal 60 mg/ml, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
N03AF02
Authorization status
Z
Dispensing category
B
First authorization
20/08/1997
Authorization expiration date
31/12/9999
IT Number
01.07.1.
Domain
Human medicine
Field of application
Antiepilepticum

Package details

Description (FR)
TRILEPTAL susp 6 % fl 100 ml
Description (DE)
TRILEPTAL Susp 6 % Fl 100 ml
Market launch
20/08/1997
Narcotic (BTM)
No

Other package sizes (1)

TRILEPTAL susp 6 % fl 250 ml
250 ML
GTIN: 7680528520131
View